Literature DB >> 20606275

Crystallization and preliminary crystallographic analysis of the Clostridium perfringens enterotoxin.

David C Briggs1, James G Smedley, Bruce A McClane, Ajit K Basak.   

Abstract

Clostridium perfringens is a Gram-positive anaerobic species of bacterium that is notable for its ability to produce a plethora of toxins, including membrane-active toxins (alpha-toxins), pore-forming toxins (-toxins) and binary toxins (iota-toxins). Here, the crystallization of the full-length wild-type C. perfringens enterotoxin is reported, which is the causative agent of the second most prevalent food-borne illness in the United States and has been implicated in many other gastrointestinal pathologies. Several crystal forms were obtained. However, only two of these optimized crystal forms (I and II) were useable for X-ray diffraction data collection. The form I crystals diffracted to d(min) = 2.7 A and belonged to space group C2, while the form II crystals diffracted to d(min) = 4 A and belonged to space group P2(1)3.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20606275      PMCID: PMC2898463          DOI: 10.1107/S1744309110016507

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  16 in total

Review 1.  Bacterial pore-forming toxins: the (w)hole story?

Authors:  M R Gonzalez; M Bischofberger; L Pernot; F G van der Goot; B Frêche
Journal:  Cell Mol Life Sci       Date:  2008-02       Impact factor: 9.261

2.  Structure of the claudin-binding domain of Clostridium perfringens enterotoxin.

Authors:  Christina M Van Itallie; Laurie Betts; James G Smedley; Bruce A McClane; James M Anderson
Journal:  J Biol Chem       Date:  2007-10-31       Impact factor: 5.157

Review 3.  Disparate proteins use similar architectures to damage membranes.

Authors:  Gregor Anderluh; Jeremy H Lakey
Journal:  Trends Biochem Sci       Date:  2008-09-06       Impact factor: 13.807

4.  Detecting and overcoming crystal twinning.

Authors:  T O Yeates
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  Production, purification, and assay of Clostridium perfringens enterotoxin.

Authors:  J L McDonel; B A McClane
Journal:  Methods Enzymol       Date:  1988       Impact factor: 1.600

6.  Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin.

Authors:  James G Smedley; Francisco A Uzal; Bruce A McClane
Journal:  Infect Immun       Date:  2007-02-16       Impact factor: 3.441

7.  New insights into the cytotoxic mechanisms of Clostridium perfringens enterotoxin.

Authors:  Bruce A McClane; Ganes Chakrabarti
Journal:  Anaerobe       Date:  2004-04       Impact factor: 3.331

Review 8.  Human disease associated with Clostridium perfringens enterotoxin.

Authors:  R R Meer; J G Songer; D L Park
Journal:  Rev Environ Contam Toxicol       Date:  1997       Impact factor: 7.563

Review 9.  Clostridial enteric infections in pigs.

Authors:  J Glenn Songer; Francisco A Uzal
Journal:  J Vet Diagn Invest       Date:  2005-11       Impact factor: 1.279

Review 10.  The mechanism of pore formation by bacterial toxins.

Authors:  Sarah J Tilley; Helen R Saibil
Journal:  Curr Opin Struct Biol       Date:  2006-03-24       Impact factor: 6.809

View more
  2 in total

1.  Crystal structure of Clostridium perfringens enterotoxin displays features of beta-pore-forming toxins.

Authors:  Kengo Kitadokoro; Kousuke Nishimura; Shigeki Kamitani; Aya Fukui-Miyazaki; Hirono Toshima; Hiroyuki Abe; Yoichi Kamata; Yoshiko Sugita-Konishi; Shigeki Yamamoto; Hajime Karatani; Yasuhiko Horiguchi
Journal:  J Biol Chem       Date:  2011-04-12       Impact factor: 5.157

2.  Structure of the food-poisoning Clostridium perfringens enterotoxin reveals similarity to the aerolysin-like pore-forming toxins.

Authors:  David C Briggs; Claire E Naylor; James G Smedley; Natalya Lukoyanova; Susan Robertson; David S Moss; Bruce A McClane; Ajit K Basak
Journal:  J Mol Biol       Date:  2011-08-03       Impact factor: 5.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.